Matches in SemOpenAlex for { <https://semopenalex.org/work/W1891543308> ?p ?o ?g. }
- W1891543308 endingPage "E142" @default.
- W1891543308 startingPage "E131" @default.
- W1891543308 abstract "Hashimoto K, Yamamoto H, Shiratsuchi H, Nakashima T, Tamiya S, Nishiyama K, Higaki Y, Komune S, Tsuneyoshi M & Oda Y (2012) Histopathology 60, E131–E142 neu gene amplification in carcinoma ex pleomorphic adenoma in relation to progression and prognosis: a chromogenic in-situ hybridization study Aims: The aim of this study was to investigate the potential role of HER-2/neu in the stepwise progression of carcinoma ex pleomorphic adenoma (CXPA) and to evaluate its prognostic significance in CXPA. Methods and results: We examined HER2 overexpression and HER2 amplification by immunohistochemistry and chromogenic in-situ hybridization in 31 cases of CXPA with ductal differentiation (eight intraductal, five intracapsular, and 18 extracapsular) and seven cases of atypical pleomorphic adenoma (PA). HER2 overexpression and HER2 amplification were found in 17 (54.8%) and 12 (38.7%) of the 31 CXPA cases, respectively. HER2 amplification was more prevalent in extracapsular CXPAs (9/18 cases; 50%) than intracapsular CXPAs (1/5 cases; 20%), intraductal CXPAs (2/8 cases; 25%), or atypical PAs (0/7 case; 0%). The status of HER2 amplification was essentially retained from the intraductal to the extracapsular component in individual extracapsular CXPAs. In addition, HER2 amplification was significantly associated with a worse prognosis (shorter disease-free survival time and shorter overall survival time) among extracapsular CXPAs (each P < 0.05). Conclusions: These results suggest that HER2 may play an important role in the progression of CXPA, and that HER2 amplification may be an additional prognostic indicator of CXPA." @default.
- W1891543308 created "2016-06-24" @default.
- W1891543308 creator A5025082835 @default.
- W1891543308 creator A5030342167 @default.
- W1891543308 creator A5036148363 @default.
- W1891543308 creator A5041401659 @default.
- W1891543308 creator A5045255482 @default.
- W1891543308 creator A5049884976 @default.
- W1891543308 creator A5053242194 @default.
- W1891543308 creator A5059655909 @default.
- W1891543308 creator A5077783838 @default.
- W1891543308 creator A5085758599 @default.
- W1891543308 date "2012-04-04" @default.
- W1891543308 modified "2023-10-09" @default.
- W1891543308 title "HER-2/neu gene amplification in carcinoma ex pleomorphic adenoma in relation to progression and prognosis: a chromogenic in-situ hybridization study" @default.
- W1891543308 cites W1966467322 @default.
- W1891543308 cites W1977891261 @default.
- W1891543308 cites W1983768759 @default.
- W1891543308 cites W1989796158 @default.
- W1891543308 cites W2006600314 @default.
- W1891543308 cites W2024170532 @default.
- W1891543308 cites W2047034979 @default.
- W1891543308 cites W2050307563 @default.
- W1891543308 cites W2052015772 @default.
- W1891543308 cites W2052286628 @default.
- W1891543308 cites W2052987864 @default.
- W1891543308 cites W2055559462 @default.
- W1891543308 cites W2057572869 @default.
- W1891543308 cites W2058191098 @default.
- W1891543308 cites W2058769149 @default.
- W1891543308 cites W2062485569 @default.
- W1891543308 cites W2074304838 @default.
- W1891543308 cites W2082497313 @default.
- W1891543308 cites W2086661954 @default.
- W1891543308 cites W2089556772 @default.
- W1891543308 cites W2098827180 @default.
- W1891543308 cites W2105023567 @default.
- W1891543308 cites W2114389974 @default.
- W1891543308 cites W2120136659 @default.
- W1891543308 cites W2124596967 @default.
- W1891543308 cites W2125725404 @default.
- W1891543308 cites W2126191879 @default.
- W1891543308 cites W2130900820 @default.
- W1891543308 cites W2138523273 @default.
- W1891543308 cites W2141393790 @default.
- W1891543308 cites W2155320512 @default.
- W1891543308 cites W2157524247 @default.
- W1891543308 cites W2163947995 @default.
- W1891543308 cites W2318605753 @default.
- W1891543308 cites W4312883841 @default.
- W1891543308 doi "https://doi.org/10.1111/j.1365-2559.2012.04201.x" @default.
- W1891543308 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22486195" @default.
- W1891543308 hasPublicationYear "2012" @default.
- W1891543308 type Work @default.
- W1891543308 sameAs 1891543308 @default.
- W1891543308 citedByCount "51" @default.
- W1891543308 countsByYear W18915433082012 @default.
- W1891543308 countsByYear W18915433082013 @default.
- W1891543308 countsByYear W18915433082014 @default.
- W1891543308 countsByYear W18915433082015 @default.
- W1891543308 countsByYear W18915433082016 @default.
- W1891543308 countsByYear W18915433082017 @default.
- W1891543308 countsByYear W18915433082018 @default.
- W1891543308 countsByYear W18915433082019 @default.
- W1891543308 countsByYear W18915433082020 @default.
- W1891543308 countsByYear W18915433082021 @default.
- W1891543308 countsByYear W18915433082022 @default.
- W1891543308 countsByYear W18915433082023 @default.
- W1891543308 crossrefType "journal-article" @default.
- W1891543308 hasAuthorship W1891543308A5025082835 @default.
- W1891543308 hasAuthorship W1891543308A5030342167 @default.
- W1891543308 hasAuthorship W1891543308A5036148363 @default.
- W1891543308 hasAuthorship W1891543308A5041401659 @default.
- W1891543308 hasAuthorship W1891543308A5045255482 @default.
- W1891543308 hasAuthorship W1891543308A5049884976 @default.
- W1891543308 hasAuthorship W1891543308A5053242194 @default.
- W1891543308 hasAuthorship W1891543308A5059655909 @default.
- W1891543308 hasAuthorship W1891543308A5077783838 @default.
- W1891543308 hasAuthorship W1891543308A5085758599 @default.
- W1891543308 hasConcept C104317684 @default.
- W1891543308 hasConcept C121608353 @default.
- W1891543308 hasConcept C126322002 @default.
- W1891543308 hasConcept C142724271 @default.
- W1891543308 hasConcept C150194340 @default.
- W1891543308 hasConcept C204232928 @default.
- W1891543308 hasConcept C2776643354 @default.
- W1891543308 hasConcept C2777428134 @default.
- W1891543308 hasConcept C2777546739 @default.
- W1891543308 hasConcept C2778937882 @default.
- W1891543308 hasConcept C2780862961 @default.
- W1891543308 hasConcept C2780885620 @default.
- W1891543308 hasConcept C2781437628 @default.
- W1891543308 hasConcept C530470458 @default.
- W1891543308 hasConcept C544855455 @default.
- W1891543308 hasConcept C55493867 @default.
- W1891543308 hasConcept C71924100 @default.
- W1891543308 hasConcept C81439078 @default.
- W1891543308 hasConcept C86803240 @default.